Barriers to conducting deprescribing in the elderly population amid the COVID-19 pandemic

• Published in: Research in social and administrative pharmacy Vol. 17; no. 1; pp. 1942 - 1945
• Main Authors: Elbeddini, Ali, Prabaharan, Thulasika, Almasalkhi, Sarah, Tran, Cindy, Zhou, Yueyang
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.01.2021; Published by Elsevier Inc
• Subjects: Aged; Canada; Computer Literacy; COVID-19; COVID-19 - prevention & control; COVID-19 - transmission; Delivery of Health Care - economics; Delivery of Health Care - organization & administration; Deprescribing; Deprescriptions; Drug safety; Drug-Related Side Effects and Adverse Reactions - prevention & control; Elderly population; Electronic Health Records; Health Care Costs; Health Services Accessibility; Humans; Polypharmacy; Quality of Life; Telemedicine; Virtual care; Canada; COVID-19; Virtual care; Elderly population; Deprescribing; Drug safety

Deprescribing aims to reduce polypharmacy, especially in the elderly population, in order to maintain or improve quality of life, reduce harm from medications, and limit healthcare expenditure. Coronavirus disease (COVID-19) is an infectious disease that has led to a pandemic and has changed the liv...